chrisvoncsefalvay/vaers-outcomes huggingface dataset:
loss of some taste; This is a spontaneous report from a contactable consumer received from the Pfizer Sponsored Program. A male patient of an unspecified age receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on 13Jan2021 at a single dose for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient was being tested weekly and he tested negative but at the same time, he was showing symptoms like loss of some taste but has no fever. Caller would like to know if ever he tested positive, if it's ok that he take typical medications. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Quiet, calm preteen. Pt. received immunizations without incidence. Pt. picked out sucker and was advised to stand up slowly. Approximately 3-4 minutes after receiving immunizations, she c/o being dizzy. Laid supine with knees bent. Pts. facial color appeared normal. Cold packs placed at nape of neck and forehead. Pt. never lost consciousness. C/o being hot and dizzy. 15:47 BP 112/64 (rt. arm) P-64, breathing normal without signs of respiratory distress. Pts. skin felt "clammy". 15:55 BP 112/70 (rt. arm) P-72. Pt. stated she had eaten breakfast and a snack prior to appointment. C/o body aches and dizziness. Assisted to a sitting position, took several sips of water. Legs and hand were trembling. C/o nausea, no vomiting. States she feels like she was "beat up". 16:00 BP 112/70 (rt. arm) P-76, R-14. C/o lower abdominal pain around umbilicus. States pain is less when pressure is applied (mother of child was firmly stroking lower abdomen). Feet held above level of heart, trembling in legs disappeared. Instructed to lay arms along side of body and stretch and relax finger, trembling in hands disappeared. Assisted into sitting position, drank several sips of water. Laid supine with knees bent. 16:10 BP 108/68 (rt. arm) P-72. Stated pain around umbilicus has stopped but ribs hurt with localized pain under lt. lowest rib. Pain rated on a scale from 1 (no pain) to 10 (worst pain imaginable) as a 9. At approximately 16:25 911 was called BP 118/68. 16:30 BP 128/68 P-24. Legs and hands trembling. Approximately at 16:35 paramedics arrived, pt. conversed with paramedics, vital signs taken, pt. assisted up and walked a few steps and laid down on stretcher, transported to hospital.
2nd dose given 10 days early.  First dose was administered 5/20/21.
The shot was administered and as she stood up she immediately fainted.  Patient's mom admitted patient was anxious about the shot and had had little to eat in the previous part of the day.  Patient  did return to consciousness after about 30-40 seconds and was able to go home after the event.
210 pm MMR vaccine administered subcantanous to left arm. 230 pm patient c/o itching at injection site with urticaria noted at site. C/O systemic symptoms of sob, chest pain, dizziness. Topical anticillen cream applied to site. Claritin tablet given to patient 3pm Dr notified of reaction. 330 pm Student felt ambulatory no further complaints.
Numbness to face, and left arm; headache; This is a spontaneous report from a contactable nurse (patient).  A 45-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm,on 24Jan2021 11:00 at SINGLE DOSE for COVID-19 immunization.  Medical history included sulfa drug allergy, artificial heart valve (replacement) and HTN (hypertension). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included warfarin sodium (COUMADIN), lisinopril and metoprolol.  The patient previously took omnicef [cefdinir] and experienced allergies.  On 24Jan2021 11:15, the patient experienced headache and numbness to face and left arm.  The outcome of events was recovering. Therapeutic measures taken as result of the events includes Benadryl.  Follow-up attempts are completed. The following information on the batch number has been requested.
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. The nurse reported improperly stored doses of ROTATEQ (orally, lot#, expiration date, dose and frequency not reported), were administered to an unspecified number of patients. No adverse events were reported. This isone of several reports from same reporter. Additional information has been requested.
Pt complaint of pain, redness discomfort to arm that injection was given in, pt broguht back in to MD office for assessment and noted to have cellulitis of arm that injection was given in. Antibiotics started.
Patient woke up with chills, fever 101.3 F day after receiving Tdap injection, Left deltoid soreness, mild edema Left deltoid. Using tylenol/advil PM office visit 9/10/09 & 9/15/09. Augmented 875 mg had started 9/10/09
TDaP received on 6/9/17 Left arm. On 6/11/17 had 2 enlarged, painful, swollen lumps near left clavicle. Has decreased gradually in size. Currently pea size.
She developed thrombocytopenia, probably at least in part secondary to her vaccine. See below platelet count 1 day prior to vaccination was normal, it fell to 45 approximately 2 weeks later.
Patient contacted pharmacy regarding persistent soreness in shoulder. Patient visited primary physician and thought the injection possibly caused tendonitis.
Positive Covid test March 10th. Asked for Paxlovid. Practitioner did not prescribe it. Had symptoms for maybe 5 days. Chills, Fever, Dizziness, Congestion, A small amount of chest phlegm, Sore Throat, Indigestion (a little). Head symptoms/ Chest phlegm lasted for 2 weeks, but minimal
This spontaneous report was received from a pharmacist concerning an unknown number of patient, of an unknown gender and age. Medical history and concurrent conditions were not reported.  On an unknown date the patient ws vaccinated with a dose of GARDASIL (dose, dose number, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported.   Pharmacist reported that, on an unknown date, an unspecified number of patients received improperly stored GARDASIL. No symptoms reported. This is one (1) of 3 (three) reports from the same source (MARRS 1408USA009356, 1408USA009356, 1408USA013073, and 1408USA013074). Additional information has been requested.
He began convulsing in his sleep, almost like a seizure except he woke up and became aware of what his body was doing. He could not control his body or limbs to move or stop the shaking.  He did not have a fever at the time and could not determine whether or not he felt cold. The uncontrollable shaking was consistent for about ten minutes and then continued sporadically for an hour or so, though it became much more controllable. Hours later, he has more typical symptoms like a bad headache and a fever. The shaking has not come back.
part of diluent sprayed into eye; part of diluent sprayed into eye; This case was reported by a pharmacist via call center representative and described the occurrence of occupational exposure while preparing product for administration in a female patient who received Herpes zoster (Shingrix) (batch number 54TF4, expiry date unknown) for prophylaxis.   On 28th June 2022, the patient received Shingrix. On 28th June 2022, unknown after receiving Shingrix, the patient experienced occupational exposure while preparing product for administration and exposure via eye contact. On an unknown date, the outcome of the occupational exposure while preparing product for administration and exposure via eye contact were unknown.   Additional Information: GSK Receipt Date: 28-JUN-2022 Reporter's Comment: The reporter reported that, when she was going to draw up Shingrix diluent in syringe, the needle popped off and part of the diluent sprayed into her right eye.  She had rinsed with water and reported that she would continue to do so throughout the day. The reporter consented to follow up. Additional Supportive Information: The reporter reported that, when she was going to draw up Shingrix diluent in syringe, the needle popped off and part of the diluent sprayed into her right eye, which led to occupational exposure while preparing product for administration and exposure via eye contact.
Pt. show up in ER with hives/rash all over body since morning of 10/28/09. Denies SOB. Pt. is 11 weeks gestation. Rc'd H1N1 vaccine on 10/26/09. BENADRYL every 6 hrs. as needed 10/30/2009 MD and Ed records for 10/28/2009. Dc Dx acute urticaria Patient with c/o's rash and itching. Tx: benadryl Im.      .
17 year old patient was given the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the second dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036b21a and 013a21a) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the second dose). On 21-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
Left arm puritis, site of injection..  50mg benadryl with improvement.  No sob, wheezing, oral/airway swelling
05/05 I felt dehydrated right after the shot and later developed into Flu-like symptoms. Was advised to take Tylenol and took rest. And it took about 2 weeks to recover. Took a Covid test to return to work and it came back negative. Fatigue and Headaches still occur even now.
In less than 30 minutes I experience a severe generalized headache from my forehead to my neck which lasted for approximately 40 plus hours despite taking Motrin 600 mg  every 6 hours.  On the next evening, December 23, I had a few episodes of nausea and vomiting due to the intense pressure in my head and slept after.  On December 24th the headache lessened and went away.  Over the next 4 weeks I experienced a problem with depth /spatial perception and mild balance issues.  I frequently knocked over or dropped things I was reaching for or had just picked up.  I also had no sense of depth perception when I tried to flush the toilet in a bathroom at work by using my foot as I always do so I don't touch the handle.  I called my employee health department and discussed all of these symptoms and my reluctance to get the 2nd shot with the nurse who answered the phone and she said there was nothing she could do for me and said I needed to talk to the people giving the shots (which are employees of the hospital she and I both work at!) or my dr.  The spatial, balance, and dropping/knocking things over symptoms lasted approx 5-6 weeks. I saw my dr more after the symptoms resolved and she suggested I file a VAERS report.
Stroke/Patient suffered a stroke before 2nd dose of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of stroke in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On 26th July 2022, unknown after receiving Shingrix, the patient experienced stroke (serious criteria GSK medically significant). On an unknown date, the outcome of the stroke was not recovered/not resolved.   It was unknown if the reporter considered the stroke to be related to Shingrix.  Additional Information: GSK Receipt Date: 25-Jul-2022. Reporter's Comments: The case was reported by the pharmacist. The reporter reported that the patient had a stroke since his first dose/ patient suffered a stroke before 2nd dose of Shingrix or between doses. The reporter reported that the patient was due to receive his second dose of Shigrix on 26th July 2022. No additional details were available. The reporter did not consent to follow up. Additional Supportive Information: The case US2022111230 was identified as duplicate of case US2022111231. The case US2022111230 was deleted and all future correspondence will be added in the present case US2022111231 which stands as case of record.
The medical assistant that prepared and administered the COVID vaccine diluted the vaccine in the vial and then drew up the entire vial which is a three dose vial. She administered all three doses from the vial at once. It is estimated that patient received 9-10 mcg of vaccine rather than the 3 mcg dose indicated for his age. Additionally, the vaccine was administered on the far lateral thigh rather than the correct location. The next day, he developed a fever of 100.5 prior to receiving ibuprofen/Tylenol for the next few days. He also experienced significant body aches, fatigue, and irritability. He developed a significant red and hot injection site reaction that progressed from 24-48 hours after the injection before nearly completely resolving 72 hours after the vaccine was administered.  I do have pictures of the rash and the progression if needed. About 72 hours after the injection, he had mostly returned to normal.
That night after the vaccine I felt warm and had a low-grade fever of about 99 and then the next day it was pretty much full-on body muscle aches, and not just soreness around shot site but in my arms, shoulders, back, and hips. I spent probably 2 days of just laying low because I didn't want to get up and move pretty much because of the aches. That lasted for a couple of days, and I was just really tired. The low-grade fever lasted for about a day. When I got the shot, the vaccine site was red and swollen for probably 5 days and just sore but that's pretty much what I get with vaccines.
Patient reported redness, swelling, and itching below the injection site that developed 3 days after the vaccination.  She stated that she took Benadryl for the symptoms.  2 days later, the redness and swelling subsided, but some itching remained if she did not take the Benadryl.
32/89 pt failed to maintain adequate titers 27mo post vax w/Rabies vax;
Significant shoulder pain soon after the flu shot that has gotten worse overnight.  He is in a great deal of pain the next morning.
Low grade fever, arm rash, arm pain, muscle aches, fatigue, stomach discomfort and nausea.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/1/2023 Discharge Date: 02/06/2023   PRESENTING PROBLEM: Hyponatremia [E87.1] Acute on chronic combined systolic and diastolic CHF (congestive heart failure) [I50.43] Anemia, unspecified type [D64.9] Acute COVID-19 [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: HOSPITAL COURSE: Patient is a 86 y.o. female with a past medical history paroxysmal atrial fibrillation, coronary artery disease status post CABG, peripheral artery disease, chronic combined systolic and diastolic heart failure who presented to the ED on 2/1 with c/o chest pain and SOB. Chest pain had resolved in route to ED w/ nitro x3. ASA given in ED to reach dose of 324mg day of admission. Troponin delta of +9. Cardiology contacted in ED but no recommendations as patient was chest pain free. Echo was not pursued as invasive intervention has been deferred in past.    Pt had come from rehab after recent admission at hospital due to weakness. She had developed cough 1 day prior to admission and was found to be COVID positive on room air day of admission.  Overnight after admission patient found to be hypoxic on supplemental oxygen support as result was started on dexamethasone 6 mg, and family declined remdesivir.  Total duration of steroid therapy of 10 days, with last dose of dexamethasone 0 2/12.   Ongoing goals of care conversation were held between the primary team, the patient and the family.  The patient was adamant that she would not like to come back to the hospital.  To pursue this, palliative care and hospice team were consulted.  After informational hospice meeting with the hospice team the family and patient elected not to pursue this however would like to follow-up with palliative care outpatient hence referral was placed by the palliative care team to continue to follow-up with the patient.   Pt had also been having hematuria at rehab with blood clots in urine. Eliquis held 1 day prior to admit. She had recently been restarted on aspirin as well (was not on mid-January discharge per Cardiology recs). Hematuria continued to improve during the admission with no frank blood during admission and no concerns from the patient. Given recommendations for age and weight, patient was transitioned to eliquis  2.5 mg BID and her hematuria continued improved.  Hemoglobin remained stable.   During the hospitalization required basal bolus coverage for steroid induced hyperglycemia.  After shared decision-making and discussion with the patient the family we agreed to continue home metformin and glipizide while on steroid therapy and to check blood sugars twice daily.  With the anticipation that her blood sugars will improve after completion of steroid which would only be additional 5 days. With the contingency plan if blood glucose greater than 450+ update primary care provider.   On the day of discharge, provided by Physical therapy and Occupational therapy and recommended home with assist, PT/OT and visiting nurses this was set up for the patient and referrals were placed.  On the day of discharge, patient was on room air, ambulating with the help of walker without any documented desaturations.
Redness(APPROX 4.5IN X 3IN AREA), SWELLING AND WARM TO TOUCH L DELTOID AREA, FEVER FROM 99-103, ACHEY.  Cellulitus L arm per Dr-seen 10/21/08.
armpit is aching; She had her 3rd dose yesterday; She had her 3rd dose yesterday; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A female patient of an unspecified age received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm on 18Aug2021 as dose 3, single for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient historical vaccine included first dose of BNT162B2 as dose 1, single and second dose of BNT162B2 as dose 2, single for COVID-19 immunization. On 18Aug2021, the patient experienced armpit is aching, she had her 3rd dose yesterday. It was further stated that, caller stated that she was calling about the Covid Vaccine, specifically the 3rd vaccine. She has a question about a concern. She has had no real problems with the first and 2nd dose. She had her 3rd dose yesterday and with her armpit, on the side where she got the shot, the armpit is aching. Caller wants to know if this is a normal side effect. Caller consents to safety report, but when this call handler attempts to start the safety report caller said before she answered questions she wanted to just know is this a normal side effect. The clinical outcome for all the events was reported as unknown.  Information on the lot/batch number has been requested.
About 1 min after injection, started feelinh strange. Lymphnode in armpit felt like fire.   Around minute 2, felt as if on the verge of vomiting. Tingles all over body.    Quickly after, felt hot and started sweating as if ran for miles. Incredibly dizzy and on the verge of passing out.  After around 5 minutes of head between knees, symptoms began to subside.  Around 15 to 20 minutes after injection, tounge felt large and almost felt like something was stuck in throat. Took benadryl. After 15 more minutes, tounge and throat issue subsided. 5.5 hours after injection, arm is heavy and painful to move. Feel nauseated.
By the evening of the first day, both arms were sore at the injection site and running slight fever. Slept o.k. through the night with the help of Tylenol Breakfast the following morning didn't taste quite right By about 11:45 a.m. felt nausiated(October 13th) vomiting by about 1:00 p.m, dizzy, fever
red rash noted under both arms 31OCT97 in early AM;symmetrical in design;over next 24hr rash spread to chest & abd;DPH taken w/hydrocortisone;cream applied;rash spread w/in 48hr to upper thighs;itching;dx systemic allerg rxn;
CHILLS A COUPLE OF HOURS AFTERWARDS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced chills a couple of hours afterwards. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills a couple of hours afterwards. This report was non-serious.
on adm 3NOV93 pt had petechial prupura lesions over legs, amrs & buccal mucos for 2 days; bleeding gums p/flossing pt also noticed petechial in mouth; recvd vax & ITP reoccurred 01NOV93;
The day after my 1st Covid vaccination my period stopped. I did not even spot for months with my concerns being ignored. On 9/2/21, I began pouring blood out. This has continued non stop from then. Multiple MD visits, hospital visits, lab work, ultrasounds, specialists, and with no prior issues or causes for this to be happening. A thickening and abnormal reaction of my uterine lining with shedding in a non stop uncontrollable expelling from my body. Solution to stop the bleeding is a total hysterectomy.  As a healthcare worker in this was mandated for me to keep my career. Career vs internal organs and negatively effecting my health and well being.
Hives that started when I woke up one day after shot. Started as bullseye type hives about 2 inches in diameter on my knees and thighs, and one on my eyelid. Hives spread out and started to join together into generalized swelling over 75% of my body. Started on legs, moved to arms, hands, neck, face, mouth, and back, in that order. Lots of heat, redness, and mild itching.